A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease
Public ClinicalTrials.gov record NCT05476783. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center Open-label Long Term Extension Study to Assess the Safety of TB006 in Patients Who Have Completed Protocol TB006AD2102 and in De Novo Patients With Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label long term extension study for participants with Alzheimer's disease (AD) who have completed Protocol TB006AD2102 (lead-in study) or participants who would have been eligible for the lead-in study but were not enrolled (de novo). The study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TB006. The total study duration for each participant will be up to 113 weeks.
Study identification
- NCT ID
- NCT05476783
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 119 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 15, 2022 (Actual)
- Primary completion
- Nov 17, 2023 (Actual)
- Completion
- Nov 17, 2023 (Actual)
- Last update posted
- May 6, 2026
2022 – 2023
United States locations
- U.S. sites
- 13
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Trial Site | San Diego | California | 92103 | — |
| Clinical Trial Site | Delray Beach | Florida | 33445 | — |
| Clinical Trial Site | Lady Lake | Florida | 32159 | — |
| Clinical Trial Site | Maitland | Florida | 32751 | — |
| Clinical Trial Site | Miami | Florida | 33135 | — |
| Clinical Trial Site | Miami | Florida | 33137 | — |
| Clinical Trial Site | Miami | Florida | 33165 | — |
| Clinical Trial Site | West Palm Beach | Florida | 33407 | — |
| Clinical Trial Site | Winter Park | Florida | 32789 | — |
| Clinical Trial Site | Winter Park | Florida | 32792 | — |
| Clinical Trial Site | Decatur | Georgia | 30030 | — |
| Clinical Trial Site | Matthews | North Carolina | 28105 | — |
| Clinical Trial Site | Fairfax | Virginia | 22031 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05476783, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2026 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05476783 live on ClinicalTrials.gov.